Safety, Pharmacokinetics, and Pharmacodynamics of BIRT 2584 XX Administered as Multiple Doses and Safety and Pharmacokinetics of BIRT 2584 XX Administered With and Without Food as Single Dose to Healthy Male Volunteers
Clinical trial NCT02256761 · COMPLETED
Trial details
- NCT number
- NCT02256761
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-01-01
- Primary completion
- 2005-07-01
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.